156 related articles for article (PubMed ID: 19142970)
1. Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics.
Uemura N; Nakanishi Y; Kato H; Saito S; Nagino M; Hirohashi S; Kondo T
Int J Cancer; 2009 May; 124(9):2106-15. PubMed ID: 19142970
[TBL] [Abstract][Full Text] [Related]
2. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
4. Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma.
Liu W; Yu ZC; Cao WF; Ding F; Liu ZH
World J Gastroenterol; 2006 Jun; 12(24):3929-32. PubMed ID: 16804985
[TBL] [Abstract][Full Text] [Related]
5. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
[TBL] [Abstract][Full Text] [Related]
6. T1 squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy.
Tanaka T; Matono S; Mori N; Shirouzu K; Fujita H
Ann Surg Oncol; 2014 Mar; 21(3):932-8. PubMed ID: 24232603
[TBL] [Abstract][Full Text] [Related]
7. Significance of lymph node capsular invasion in esophageal squamous cell carcinoma.
Sakai M; Suzuki S; Sano A; Tanaka N; Inose T; Sohda M; Nakajima M; Miyazaki T; Kuwano H
Ann Surg Oncol; 2012 Jun; 19(6):1911-7. PubMed ID: 22290569
[TBL] [Abstract][Full Text] [Related]
8. Decreased Expression of PDHE1α Predicts Worse Clinical Outcome in Esophageal Squamous Cell Carcinoma.
Zhong Y; Huang R; Li X; Xu R; Zhou F; Wang J; Fan H; Goscinski M; Zhang M; Wen JG; Nesland JM; Suo Z
Anticancer Res; 2015 Oct; 35(10):5533-8. PubMed ID: 26408721
[TBL] [Abstract][Full Text] [Related]
9. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
[TBL] [Abstract][Full Text] [Related]
10. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
[TBL] [Abstract][Full Text] [Related]
11. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
12. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H
Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
[TBL] [Abstract][Full Text] [Related]
13. Matrix Metalloproteinase-13 - A Potential Biomarker for Detection and Prognostic Assessment of Patients with Esophageal Squamous Cell Carcinoma.
Sedighi M; Aledavood SA; Abbaszadegan M; Memar B; Montazer M; Rajabian M; Gholamin M
Asian Pac J Cancer Prev; 2016; 17(6):2781-5. PubMed ID: 27356690
[TBL] [Abstract][Full Text] [Related]
14. Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression.
Kuo IY; Wu CC; Chang JM; Huang YL; Lin CH; Yan JJ; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Cancer; 2014 Aug; 135(3):563-73. PubMed ID: 24407731
[TBL] [Abstract][Full Text] [Related]
15. Identification of alpha-actinin 4 and 67 kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches.
Fu L; Qin YR; Xie D; Chow HY; Ngai SM; Kwong DL; Li Y; Guan XY
Cancer; 2007 Dec; 110(12):2672-81. PubMed ID: 17960614
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Sox3 is associated with diminished prognosis in esophageal squamous cell carcinoma.
Li K; Wang RW; Jiang YG; Zou YB; Guo W
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S459-66. PubMed ID: 23238694
[TBL] [Abstract][Full Text] [Related]
17. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
18. Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics.
Suehara Y; Kondo T; Seki K; Shibata T; Fujii K; Gotoh M; Hasegawa T; Shimada Y; Sasako M; Shimoda T; Kurosawa H; Beppu Y; Kawai A; Hirohashi S
Clin Cancer Res; 2008 Mar; 14(6):1707-17. PubMed ID: 18347171
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
[TBL] [Abstract][Full Text] [Related]
20. p12CDK2-AP1 is associated with tumor progression and a poor prognosis in esophageal squamous cell carcinoma.
Hiyoshi Y; Watanabe M; Hirashima K; Karashima R; Sato N; Imamura Y; Nagai Y; Yoshida N; Toyama E; Hayashi N; Baba H
Oncol Rep; 2009 Jul; 22(1):35-9. PubMed ID: 19513502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]